Skip to main content
    • Aa
    • Aa

Gait, aging and dementia

  • Judy MA Haworth (a1)

Cognitive impairment has been recognized as a risk factor for falls and for increasing the severity of injury following a fall, but the mechanisms by which cognitive impairment influences gait and postural control have been unclear. A recent report that galantamine improves gait parameters in older adults may help to untangle this.

Corresponding author
Address for correspondence: JMA Haworth, Malvern Ward, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK.
Hide All
1American Geriatric Society, British Geriatric Society and American Association of Orthopedic Surgeons panel. Guideline for the prevention of falls in older people. J Am Geriatr Soc 2001; 49: 664–72.
2Tinetti ME, Doucette J, Clais E, Marottoli R. Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc 1995; 43: 1214–21.
3Assal F, Kressig RW, Herrman FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 946–47.
4Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. Walking is more like catching than tapping gait in the elderly as a complex cognitive task. Exp Brain Research 2005; 164: 541–48.
5Sheridan PL, Hausdorff JM. The role of higher level cognitive function in gait: Executive dysfunction contributes to fall risk in Alzheimer's disease. Dement Geriatric Cogn Discord 2007; 24: 125–37.
6Dimitrijevic MR, Gerasimenko Y, Pinter MM. Evidence for a spinal central pattern generator in humans. In: Kiehn O, Harris-Warrick RM ed. Neuronal mechanisms for generating locomotor activity. New York: New York Academy of Sciences 1998; 360–76.
7Hiyamizu M, Morioka S, Matsuo A, Shomoto K. Ability to monitor and adjust one's walking pattern. [Abstract] Proceedings of second International Congress on Gait and Mental Function, Amsterdam, Feb. 2008.
8Jahn K, Deutschlander A, Stephan T, Kalla R, Strupp M, Brandt T. Imaging supraspinal control of human locomotion. [Abstract] Proceedings of second International Congress on Gait and Mental Function, Amsterdam, Feb. 2008.
9Whittle M. The gait cycle. In: Whittle M. Gait analysis, an introduction. PLACE: Butterworth Heinemann, 2007.
10Nutt JG, Marsden CD, Thompson PD. Human walking and higher level gait disorders, particularly in the elderly. Neurology 1993; 43: 268–79.
11Nutt JG. Classification of gait and balance disorders. Adv Neurol 2001; 87: 135–41.
12Murray MP, Kory RC, Clarkson BH. Walking patterns in healthy old men. J Gerontology 1969; 24: 169178.
13Murray MP, Kory RC, Sepic SB. Walking patterns of normal women. Arch Phys Med Rehabil 1970; 51: 637–50.
14Nigg BM, Fisher V, Ronsky JL. Gait characteristics as a function of age and gender. Gait Posture 1994; 2: 213–20.
15Prince E, Corriveau H, Hebert R. Gait in the elderly. Gait Posture 1997; 5: 128–35.
16Winter DA, Patla AE, Frank JS, Walt SE. Biomechanical walking pattern changes in the fit and healthy elderly. Phys Ther 1990; 70: 340–47.
17Kerrigan DC, Todd MK, Della Croce U, Lipsitz LA, Collins JJ. Biomechanical gait alterations independent of speed in the healthy elderly: evidence for specific limiting impairments. Arch Phys Med Rehabil 1998; 79: 317–22.
18McIlroy WE, Maki BE. Age-related changes in compensatory stepping in response to unpredictable perturbations. J Gerontol Med Sci 1996; 51A: M289M296.
19Maki BE. Gait changes in older adults: Predictors of falls or indicators of fear? J Am Geriatr Soc 1997; 45: 313–20.
20Wolfson LI, Whipple R, Amerman P, Kleinberg A. Stressing the postural response, a quantitative method for testing balance. J Am Geriatr Soc 1986; 34: 845–45.
21Krishnamurthy M, Vergese J. Gait characteristics in nondisabled community residing nonagenarians. Arch Phys Med Rehabil 2006; 87: 541–45.
22Woo J, Ho SC, Lau J, Chan SG, Yuen YK. Age-associated gait changes in the elderly: Pathological or physiological? Neuroepidemiol 1995; 14: 6571.
23Bendall MJ, Bassey EJ, Pearson MB. Factors affecting walking speed of elderly people. Age Ageing 1989; 18: 327–32.
24Dobbs RJ, Lubel DD, Charlett A et al. Hypothesis: Age-associated changes in gait represent in part, a tendency towards parkinsonism. Age Ageing 1992; 21: 221–25.
25Wolfson L, Whipple R, Amerman P, Tobin JN. Gait assessment in the elderly: a gait abnormality rating scale and its relation to falls. J Gerontol 1990; 45: M1219.
26Hausdorff JM, Edelberg HK, Mitchell SL, Goldberger AL, Wei JY. Increased gait unsteadiness in community dwelling elderly fallers. Arch Phys Med Rehabil. 1997; 78: 278–83.
27Oberg T, Karsznia A, Oberg K. Basic gait parameters: reference data for normal subjects, 10–79 years of age. J Rehabil Res Dev 1993; 30: 210–23.
28Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79: reference values and determinants. Age Ageing 1997; 26: 1519.
29Samson MM, Crowe A, de Vreede PL, Dessens JA, Duursma SA, Verhaar HJ. Differences in gait parameters at a preferred walking speed in healthy subjects due to age, height and body weight. Aging (Milano) 2001; 13: 1621.
30Maylor EA, Wing AM. Age differences in postural stability are increased by additional cognitive demands. J Gerontol: Psychol Sci 1996; 51: 143–54.
31Beauchet O, Dubost V, Aminian K, Gonthier R, Kressig RW. Dual task-related gait changes in the elderly: Does the type of cognitive task matter? J Motor Beh 2005; 37: 259–64.
32Ble A, Volpato S, Zuliani G et al. Executive function correlates with walking speed in older persons: The InCHIANTI Study. J Am Geriatr Soc 2005; 53: 410–15.
33Bock O, Engelhard K, Guardiera P, Allmer H, Kleinert J. Conditions for increased dual task costs of walking in the elderly. [Abstract] proceedings of second International Congress in Gait and Mental Function., Amsterdam, Feb 2008.
34Berkmann L F, Seeman T E, Albert M et al. High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol 1993; 46: 1129–40.
35Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332: 556–61.
36Ramakers IH, Visser PJ, Aalten P et al. Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cog Disord 2007; 24: 300–06.
37Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer's dementia. New Engl J Med 2002; 347: 1761–68.
38Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 2007; 78: 929–35.
39Wang L, Larson EB, Bowen JD, van Belle G. Performance-based physical function and future dementia in older people. Arch Int Med 2006; 166: 1115–20.
40Abbott RD, White LR, Webster Ross G, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. J Am Med Assoc 2004; 292: 1447–53.
41Weuve J, Kang JH, Manson JE, Breteler MB, Ware JH, Grodstein F. Physical activity, including walking and cognitive function in older women. J Am Med Assoc 2004; 292: 1454–61.
42Kramer AF, Hahn S, Cohen NJ et al. Ageing, fitness and neurocognitive function. Nature 1999; 400: 416–19.
43Stones MJ, Dawe D. Acute exercise facilitates semantically cued memory in nursing home residents. J Am Geriatr Soc 1993; 41: 531–34.
44EJA Van Paasschen J, Deijen JB et al. Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment Health 2005; 9: 272–80.
45McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of Alzheimer's disease; Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939–44.
46Ala TA, Frey WH. Validation of the NINCDS-ADRDA criteria regarding gait in the clinical diagnosis of Alzheimer's disease. A clinicopathological study. Alzheimer Dis Assoc Disord 1995; 9: 152–59.
47Visser H. Gait and balance in senile dementia of Alzheimer's type. Age Ageing 1983; 12: 296301.
48O'Keefe ST, Kazeem H, Philpott RM, Playfer JR, Gosney M, Lye M. Gait disturbance in Alzheimer's disease. A clinical study. Age Ageing 1996; 25: 313–16.
49Bazner H, Oster M, Daffertshofer M, Hennerici M. Assessment of gait in subcortical vascular encephalopathy by computerised analysis; a cross-sectional and longitudinal study. J Neurol 2000; 247: 841–49.
50Cummings JL. Vascular subcortical dementias. Clinical aspects. Dementia 1994; 5: 177–80.
51van Iersel MB, Hoefsloot W, Munneke M, Bloem BR, Olde Rikkert MGM. Systematic review of quantitative clinical gait analysis in patients with dementia. Z Gerontol Geriatr 2004; 37: 2732.
52Waite IM, Broe GA, Grayson DA, Creasey H. Motor function and disability in the dementias. Int J Geriatr Psychiatry 2000; 15: 897903.
53Merory JR, Wittwer JE, Rowe CC, Webster KE. Quantitative gait analysis in patients with Lewy bodies and Alzheimer's disease. Gait Posture 2007; 26: 414–19.
54van Iersal MB, Verbeek ALM, Bloem BR, Munneke M, Esselink RAJ, Olde Rikkert MGM. Frail elderly patients with dementia go too fast. J Neurol Neurosurg Psychiatry 2006; 77: 874–76.
55Pettersson AF, Olsson E, Wahlund L-O. Motor function in subjects with mild cognitive impairment and early Alzheimer's disease. Dement Geriatr Cogn Disord 2005; 19: 299304.
56Franssen EH, Souren LE, Torossian CL, Reisberg B. Equilibrium and limb co-ordination in mild cognitive impairment and mild Alzheimer's disease. J Am Geriatric Soc 1999; 47: 463–69.
57Gerolodi C, Ferrucci L, Bandinelli S et al. Mild cognitive deterioration with sub-cortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InChIANTI Study). J Am Geriatr Soc 2003; 51: 1064–71.
58Boyle PA, Wilson RS. Lower-extremity motor function and disability in mild cognitive impairment. Exp Aging Res 2007; 33: 355–71.
59Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive jmpairment and the risk of incident Alzheimer disease. Arch Neurol 2006; 63: 1763–69.
60Sheridan PL, Solomont J, Kowall N et al. . Influence of executive function on locomotor function: Divided attention increases gait variability in Alzheimer's disease. J. Am Geriatr Soc 2003; 51: 1633–37.
61Cocchini G, Della Sala S, Logie RH, Pagani R, Sacco L, Spinnler H. Dual task effects of walking when talking in Alzheimer's disease. Rev Neurol (Paris) 2004; 160: 7480.
62Adams RL, Parsons OA, Culbertson JL et al. Neuropsychology for clinical practice: etiology, assessment and treatment of common neurologic disorders. Washington DC. American Psychological Association, 1996.
63Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary, second edition. New York: Oxford University Press, 1998.
64Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer's disease: a critical review. Brain 1999; 122: 383404.
65Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer's disease. Brain 2001; 124: 14921508.
66Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldst D eds. Recent developments in Parkinson's disease. (Vol 12). Florham Park, NJ.: MacMillan Health Information; 1987 153–63.
67Ashe M, Nagamatsu L, Katarynych L, Liu-Ambrose TYL. Key processes of executive function underlying dual tasking. [Abstract] Proceedings of second International Congress on Gait and Mental Function, Amsterdam, Feb. 2008.
68Heuninckx S, Wenderoth N, Debaere F. Neural basis of aging: the penetration of cognition into action control. J Neurosci 2005; 25: 6787–96.
69Patel I, Turano KA, Broman AT, Bandeen-Roche K, Munoz B, West SK. Measures of visual function and percentage of preferred walking speed in older adults: The Salisbury Eye Evaluation Project. Investigative ophthalmology and visual science 2006; 47: 6571.
70Pearson RCA, Esiri MM, Hiorns RW. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proceedings of the National Academy of Sciences, USA 1985; B2: 4531–34.
71Arnold SE, Hyman BT, Flory J, Damasio AR, Van-Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991; 1: 103–16.
72Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 17991808.
73Cronin-Golomb A. Vision in Alzheimer's disease. The Gerontologist 1995; 35: 370–76.
74Rizzo M, Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain 1998; 12: 2259–70.
75Mittenberg W, Malloy M, Petrick J, Knee K. Impaired depth perception discriminates Alzheimer's dementia from aging and major depression. Arch Clin Neuropsychol 1994; 9: 71–9.
76Tales A, Haworth J, Nelson S, Snowden RJ, Wilcock GK. Abnormal visual search in mild cognitive impairment and Alzheimer's disease. Neurocase 2005; 11: 8084.
77Tales A, Haworth J, Wilcock GK, Newton P, Butler S. Visual mismatch negativity highlights abnormal pre-attentive visual processing in mild cognitive impairment and Alzheimer's disease. Neuropsychologica 2008; 46: 1224–32.
78Kosnik W, Winslow I, Kline D, Rasinski K, Sekuler R. Visual changes in daily life through adulthood. J Gerontol B Psychol Sci Soc Sci 1988; 43B: P63P70.
79Owsley C, McGwin G. Association between visual attention and mobility in older adults. J Am Geriatr Soc 2004; 52: 1901–06.
80Fukuyama H, Ouchi Y, Matsuzaki S et al. Brain functional activity during gait in normal subjects: a SPECT study. Neurosci Lett 1997; 228: 183–86.
81Riecker A, Wildgreber D, Mathiak K et al. Parametric analysis of rate-dependent hemodynamic response functions of cortical and subcortical brain structures during auditorily cued finger-tapping: a fMRI study. Neuroimage 2003; 18: 731–39.
82Jahn K, Deutschlander A, Stephan T, Kalla R, Strupp M, Brandt T. Imaging supraspinal control of human locomotion. [Abstract] Proceedings of second International Congress on Gait and Mental Function, Amsterdam, Feb 2008.
83Zehr EP, Balter DP, Ferris SR, Hundza SR, Loadman PM, Stoloff RH. Neural regulation of rhythmic arm and leg movement is conserved across human locomotor tasks. J Physiol 2007; 582: 209–27.
84Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988:51: 540–43.
85Christensen LO, Johannsen P, Sinkjaer T, Petersen N, Pyndt HS, Nielsen JB. Cerebral activation during bicycle movements in man. Exp Brain Res 2000; 135: 6672.
86Malouin F, Richards CL, Jackson PL, Dumas F, Doyon J. Brain activations during motorimagery oflocomotor-related tasks: a PET study. Hum Brain Mapp 2003; 19: 4762.
87Kerber K, Enrietto JA, Jacobson KM, Baloh RW. Disequilibrium in older people: a prospective study. Neurology 1998; 51: 574–80.
88Guo X, Steen B, Matousek M et al. A population-based study on brain atrophy and motor performance in elderly women. J Gerontol Med Sci 2001; 56: 633–37.
89Weiner SI, Berthoz A, Zugaro MB. Multisensory processing in the elaboration of place and head direction responses by limbic system neurons. Cogn Brain Res 2002; 14: 7590.
90Jordan K, Schadow J, Wuestenberg T, Heinze HJ, Jancke L. Different cortical activations for subjects using allocentric or egocentric strategies in a virtual navigation task. Neuroreport 2004; 15: 135–40.
91Ellis JR, Ellis KP, Bartholemeusz CF et al. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J N Neuropsychopharmacol 2006; 9: 175–89.
92Bennett D, Beckett L, Murray A et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Eng J Med 1996; 334: 7176.
93Schneider JA, Li J, Li Y, Wilson RS, Kordower JH, Bennett DA. Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 2006; 59: 166–73.
94Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident Alzheimer's disease in older persons. Arch Neurol 2003; 60: 539–44.
95Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993; 43: 2184–88.
96Ferrucci L, Penninx BW, Volpato S et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002; 50: 1947–54.
97Philips MI. Function of angiotensin in the central nervous system. Annu Rev Physiol 1987; 49: 413–35.
98Croog SH, Levine S, Testa MA et al. The effects of antihypertensive therapy on the quality of life. New Engl J Med 1986; 314: 1657–64.
99Barnes JM, Barnes NM, Costall B et al. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res 1990; 507: 341–43.
100Domeney AM. Angiotensin-converting enzyme inhibitors as potential cognitive enhancing agents. J Psychiatr Neurosci 1994; 19: 4650.
101Nebes RD, Pollock BG, Halligan EM, Kirshner MA, Houck PR. Serum anticholinergic activity and motor performance in elderly persons. J Gerontol A Biol Sci Med Sci 2007; 62A: 8386.
102Cao YJ, Mager DE, Simonsick EM et al. Physical and cognitive performance and the burden of anticholinergics, sedatives and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83: 422–29.
103Kaasinen V, Nâgren K, Järvenpää T et al. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease. J Clin Psychopharmacol 2002; 22 615–20.
104Giacobini E, Spiegel R, Enz A, Veroff AE, Cutler NR. Inhibition of acetyl and butyrylcholinesterase in the CSF of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit. J Neurol Transm 2002; 109: 1053–65.
105Maelicke A, Albuquerque EX. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol 2000; 393: 165–70.
106Sharp BM, Yatsula M, Fu Y. Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats. J Pharmacol Exp Ther 2004; 309: 1116–23.
107Geerts H, Lazarewicz M, Spiros A et al. Galantamine benefits in Alzheimer's disease are related to increases in dopamine output. Schizophrenia Res 2003; 60 (suppl)135.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 2
Total number of PDF views: 20 *
Loading metrics...

Abstract views

Total abstract views: 149 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.